Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

ACTIVE NOT RECRUITING

NCT07421739

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Sponsor: Aura Biosciences

View on ClinicalTrials.gov

Summary

To assess subject-centric evidence of QoL outcomes in a subset of subjects enrolled in the global Phase 3 AU-011-301 clinical trial.

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

Start Date

2025-11-12

Completion Date

2028-08-15

Last Updated

2026-10-22

Healthy Volunteers

Conditions

Choroidal Melanoma Indeterminate Lesions Uveal Melanoma Ocular Melanoma

Interventions

OTHER

Non-interventional, digital, patient-reported, study

Surveys will be collected at the following CoMpass trial visits. Scheduled visits: Visit 2 Visit 8 Visit 19 Visit 20 Visit 22 Visit 25 Visit 26 Visit 27 Visit 28 Visit 29 And any SOC (Standard of care) Visit

Locations (1)

Eye Research Australia

East Melbourne, Victoria, Australia